Form 4: Director Mark Weinberger Acquires JNJ Deferred Share Units
Statement of Changes in Beneficial Ownership
Johnson & Johnson Director Mark Weinberger acquired 975 deferred share units as part of the company's director compensation plan.
Summary
- Director Mark Weinberger was granted 975 Deferred Share Units (DSUs) on April 23, 2026.
- The DSUs were acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors.
- These units are to be settled in cash upon the termination of the director's service.
- Following this transaction, the director's total beneficial ownership increased to 12,010.408 units.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral, routine administrative filing regarding director compensation with no impact on company operations or financial strategy.
Positives
- Demonstrates continued alignment between board members and company performance through equity-based compensation.
- The acquisition reflects standard director compensation practices.
Negatives
- None identified.
Risks
- Value of deferred share units is tied to the future market performance of Johnson & Johnson common stock.
Future Outlook
The filing does not provide forward-looking financial guidance for the company.
Industry Context
StockSavvy.ai notes that this is a routine disclosure of director compensation, consistent with standard corporate governance practices among large-cap pharmaceutical companies where board members are incentivized through equity-linked instruments.
Comparison to Industry Standards
- The use of Deferred Fee Plans for directors is a standard practice among S&P 500 companies to align board interests with long-term shareholder value.
- The reporting of these grants via Form 4 is in full compliance with SEC Section 16 requirements.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Power of Attorney | Appointment of attorneys-in-fact for SEC filing purposes. | 2025-12-03 | Administrative update to ensure timely regulatory compliance. |
Stakeholder Impact
- No material impact on shareholders, employees, or creditors.
Next Steps
- The director will continue to hold these units until the termination of their directorship.
Key Dates
| Date | Description |
|---|---|
| 2025-12-03 | Date of Power of Attorney execution. |
| 2026-04-23 | Date of the earliest transaction involving the acquisition of DSUs. |
| 2026-04-27 | Date of filing. |
Keywords
Johnson & Johnson, JNJ, Director Compensation, Deferred Share Units, Insider Transaction, Form 4
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.